Browsing by Author Fusi, Fabio


Or, select a letter below to browse by last name
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 82  next >
Issue DateTitleAuthor(s)Third Mission
20012,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+ channel via superoxide anion generation.Fusi, Fabio ; Saponara, Simona; Gagov, H.; Sgaragli, GIAN PIETRONot applicable
19992,5-Di-t-butyl-1,4-benzohydroquinone induces endothelium-dependent relaxation of rat thoracic aortaFusi, Fabio ; Valoti, Massimo; Frosini, Maria; Sgaragli, GIAN PIETRONot applicable
20132-Aryl- and 2-amido-benzothiazoles as multifunctional vasodilators on rat artery preparationsFusi, Fabio ; Durante, Miriam; Sgaragli, GIAN PIETRO; Cuong, N. M.; Dung, P. T. P.; Nam, N. H.Not applicable
20123,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibilityLacava, C.; Michalek Sauberer, A.; Kraft, B.; Sgaragli, G.; Sipos, E.; Höller, C.; Kress, H. G.; Fusi, Fabio ; Weigl, L. G.Not applicable
20013,5-Di-t-butyl-4-hydroxyanisole (DTBHA) activation of rat skeletal muscle sarcoplasmic reticulum Ca2+-ATPase.Fusi, Fabio ; Tzankova, V; Valoti, Massimo; Pessina, Federica; Sgaragli, GIAN PIETRONot applicable
20053,5-di-t-butylcatechol (DTCAT) as an activator of rat skeletal muscle ryanodine receptor Ca2+ channel (RyRC).Fusi, Fabio ; Iozzi, D.; Sgaragli, GIAN PIETRO; Frosini, MariaNot applicable
20123,5-Di-t-butylcatechol as a ryanodine receptor agonist in rat intact skeletal muscle fibersLacava, C.; Sgaragli, G.; Fusi, Fabio Not applicable
20043,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility.Saponara, Simona; Kawase, M; Shak, A; Motohashi, N; Molnar, J; Ugocsai, K; Sgaragli, GIAN PIETRO; Fusi, Fabio Not applicable
20073,5-dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7): a new multidrug resistance inhibitor devoid of effects on Langendorff-perfused rat heart.Saponara, Simona; Ferrara, A; Gorelli, B; Shah, A; Kawase, M; Motohashi, N; Molnar, J; Sgaragli, GIAN PIETRO; Fusi, Fabio Not applicable
2009Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profileBova, S; Saponara, Simona; Rampa, A; Gobbi, S; Cima, L; Fusi, Fabio ; Sgaragli, GIAN PIETRO; Cavalli, M; DE LOS RIOS, C; Striessnig, J; Bisi, A.Not applicable
2020Antihypertensive, cardio-and neuroprotective effects of Tenebrio molitor (Coleoptera: Tenebrionidae) defatted larvae in spontaneously hypertensive ratsPessina, F.; Frosini, M.; Marcolongo, P.; Fusi, Fabio ; Saponara, S.; Gamberucci, A.; Valoti, M.; Giustarini, Daniela ; Fiorenzani, P.; Gorelli, B.; Francardi, V.; Botta, Maurizio ; Dreassi, Elena Not applicable
2018Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]- N -[(piperidin-4-yl)methyl]methanamine (MMV019918) and analoguesVallone, Alessandra; D'Alessandro, Sarah; Brogi, Simone; Brindisi, Margherita ; Chemi, Giulia ; Alfano, Gloria; Lamponi, Stefania ; Lee, Soon Goo; Jez, Joseph M.; Koolen, Karin J. M.; Dechering, Koen J.; Saponara, Simona; Fusi, Fabio ; Gorelli, Beatrice; Taramelli, Donatella; Parapini, Silvia; Caldelari, Reto; Campiani, Giuseppe ; Gemma, Sandra ; Butini, Stefania Not applicable
2020The beneficial health effects of flavonoids on the cardiovascular system: focus on K+ channelsFusi, Fabio ; Trezza, Alfonso ; Tramaglino, M; Sgaragli, G; Saponara, S; Spiga, Ottavia Not applicable
2002Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes.Fusi, Fabio ; Saponara, Simona; Sgaragli, GIAN PIETRO; Cargnelli, G; Bova, S.Not applicable
1993Calcium antagonist and antiperoxidant properties of some hindered phenols.Sgaragli, GIAN PIETRO; Valoti, Massimo; Gorelli, Beatrice; Fusi, Fabio ; Palmi, Mitri; Mantovani, PieroNot applicable
2006Calcium channel antagonists discovered by a multidisciplinary approachCarosati, Emanuele; Cruciani, Gabriele; Chiarini, Alberto; Budriesi, Roberta; Ioan, Pierfranco; Spisani, Raffaella; Spinelli, Domenico; Cosimelli, Barbara; Fusi, Fabio ; Frosini, Maria; Matucci, Rosanna; Gasparrini, Francesco; Ciogli, Alessia; Stephens, Philip J.; Devlin, Frank J.Not applicable
1997Can food antioxidants prevent cancer and cardiovascular diseases?Fusi, Fabio ; Marazova, K; Pessina, Federica; Petri, C. AND SGARAGLI G. P.Not applicable
2006Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivativesFusi, Fabio ; Saponara, S; Valoti, M; Dragoni, S; D'Elia, P; Sgaragli, T; Alderighi, D; Sgaragli, G.Not applicable
2010Cardamonin is a bifunctional vasodilator that inhibits Cav1.2 current and stimulates KCa1.1 current in rat tail artery myocytesFusi, Fabio ; Cavalli, M; Mulholland, D; CROUCH N., R; Coombes, P; Dawson, G; Bova, S; Sgaragli, G.; Saponara, SimonaNot applicable
2017Cav1.2 channel current block by the PKA inhibitor H-89 in rat tail artery myocytes via a PKA-independent mechanism: Electrophysiological, functional, and molecular docking studiesFusi, Fabio ; Trezza, Alfonso ; Spiga, Ottavia ; Sgaragli, Giampietro; Bova, SergioNot applicable